Sarepta Therapeutics, Inc. (SRPT) › Cost of RevenueSarepta Therapeutics, Inc. (SRPT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2025$25.50M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share